Register Now to Participate in the Upcoming Webinar!
Tuesday, June 30, 2026 | 6:00-7:00pm ET
Short stature is a common presentation in pediatric endocrinology, with many patients ultimately classified as having idiopathic or familial short stature. However, underlying genetic conditions such as hypochondroplasia may be under-recognized due to variable and often subtle clinical features.
Learning objectives:
Describe key considerations in short stature evaluation, including features suggestive of hypochondroplasia
Recognize clinical findings and growth patterns that may prompt further evaluation for hypochondroplasia
Discuss the role of new diagnostic guidelines in supporting accurate diagnosis and clinical management
Join us for a conversation featuring
Chief of Endocrinology
Children’s National Hospital
Associate Professor of Pediatrics
George Washington University
School of Medicine and Health Sciences
Washington, District of Columbia
Additional Faculty to Be Announced.
This session will review key considerations in short stature evaluation that may prompt suspicion for hypochondroplasia, with a focus on clinical recognition and diagnostic assessment.
The application of new diagnostic guidelines will be discussed, highlighting opportunities to support earlier and more accurate diagnosis and inform clinical management.
Register now
This website and educational program have been produced and fully funded by BioMarin.
This Website is intended for Healthcare Professionals only.
If you have questions or need any additional information about the Webinar, please contact us at questions@inbiopharma.com.
BioMarin Pharmaceutical Inc. complies with the Open Payments Act and the PhRMA Guidelines. This event is not eligible for CME credits.